Attachmenta Analytical Beaute ft Stg a n h if^ s PJtGt40f'4 EID871404 3058 Research Drive State College, PA 16801 research Phone: 814-272-1039 Fax: 814-231-1580 Lodin Login Groupi LOOQ3GGO Login#: Project 3110 P0000959 Company Name: DuPont da Nemours & Co, Ina Submitted By.

AR226-3112 S ABIO TIC DEG RADATIO N: H YDRO LYSIS A S A FUN C TIO N O F pH (PR ELIM INA RY TEST) Sponsor DuPont Specialty Chemicals Jackson Laboratory Chambers Works Deepwater NJ 08023 USA Research Laboratory Huntingdon Life Sciences Ltd Eye Suffolk IP23 7PX ENGLAND Draft: 23 December 1998 Final: 2 February 1999 aswpssif SanHteed.

The vapor phase scavenging coefficients used were based on calculations by DuPont which were submitted under the Consent Order.

AR226-3135 TRADE SECRET Study Title H-24256: Local Lymph Node Assay (LLNA) Laboratory Project ID: DuPont-3548 AUTHOR: Gregory S.

El DuPont de Nemours Company.

vt EXPOSURE EVALUATION FOR NEW PROCESS AT FAYETTEVILLES1TE Prepared by DuPont Engineering Technology Debbie Mulrooriey Cathie Barton August 20, 2001 EID293775 TABLE OF CONTENTS Executive Summary 1.

The internal standards used were a dual labeled PFOS where two '*0 molecules were included in the sulfonate group (intemal standard, >99% purity, synthesized by Research Triangle Institute, Research Triangle Park, NC) and a dual labeled PFOA molecule, where the carboxyl and alpha carbons were labeled with C stable isotope (greater than 97%, provided by DuPont, `Wilmington, DE).

Jepson The DuPont Company, Haskell Laboratory for Health and Environmental Sciences, Newark, Delaware, USA Abstract A large r |TMnTMmHnMir-database exists describing the behavior of perfluorooctanoic acid (PFOA) following oral exposure- The objective of this study was to quantify plasma PFOA concentrations to rats, following single and repeated inhalation exposures at three airborne concentrations, for the purpose o fbridging the oral and iniialation exposure data sets.

Date Stait Due ttate Received Date Received By Spread Sample: 3110 P0000959 DuPont do Nemours & Cc, Inc.

The vapor phase scavenging coefficients used were based on calculations by DuPont which were submitted under the Consent Order.

ARRRE 3307 480 ~~ CHROMOSOMAL ABERRATION TEST RESULTS USING MAMMALIAN CULTURE CELLS EE 1.

AR226-3107 CONFIDENTIAL DPT 430/984441/SE Sponsor * DuPont-Speciality Chemicals Jackson Laboratory Chambers Works Deepwater NJ 08023 USA Research Laboratory Huntingdon Life Sciences Ltd' P.O.

Petit English Translation of Report Summary for DuPont Chemical Solutions Enterprise 27-Jan-03 S a r n ia .

P-1 D O&06- OO June 19, 2006 06 JUN20 AM 6*09 DuPont Haskell Laboratory M for Health and'Environmental Sciences Elkton Road, P.O.

AR226-3147 TRADE SECRET Study Title H-24335: Local Lymph Node Assay (LLNA) Laboratory Project ID: DuPont-3823 AUTHOR: Gregory S.